The efficacy and safety indices were 1.25 ± 0.38 and 1.41 ± 0.34, respectively. At 6 months, the SE was within ☐.50 D of emmetropia in 30 (70%) eyes and within ☑.00 D of emmetropia in 39 (91%) eyes. In this retrospective single-surgeon case series, manifest refraction, visual acuities, endothelial cell density (ECD), and pIOL rotation were evaluated over 6 months. To evaluate the refractive results and rotational stability of Eyecryl toric phakic intraocular lens (pIOL).
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |